114 related articles for article (PubMed ID: 38457838)
1. An automated methodology for whole-body, multimodality tracking of individual cancer lesions.
Santoro-Fernandes V; Huff DT; Rivetti L; Deatsch A; Schott B; Perlman SB; Jeraj R
Phys Med Biol; 2024 Apr; 69(8):. PubMed ID: 38457838
[No Abstract] [Full Text] [Related]
2. Development and validation of a longitudinal soft-tissue metastatic lesion matching algorithm.
Santoro-Fernandes V; Huff D; Scarpelli ML; Perk TG; Albertini MR; Perlman S; Yip SSF; Jeraj R
Phys Med Biol; 2021 Jul; 66(15):. PubMed ID: 34261045
[TBL] [Abstract][Full Text] [Related]
3. Qualitative and quantitative comparison of PET/CT and PET/MR imaging in clinical practice.
Al-Nabhani KZ; Syed R; Michopoulou S; Alkalbani J; Afaq A; Panagiotidis E; O'Meara C; Groves A; Ell P; Bomanji J
J Nucl Med; 2014 Jan; 55(1):88-94. PubMed ID: 24337608
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of
Sawicki LM; Deuschl C; Beiderwellen K; Ruhlmann V; Poeppel TD; Heusch P; Lahner H; Führer D; Bockisch A; Herrmann K; Forsting M; Antoch G; Umutlu L
Eur Radiol; 2017 Oct; 27(10):4091-4099. PubMed ID: 28439648
[TBL] [Abstract][Full Text] [Related]
5. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
[TBL] [Abstract][Full Text] [Related]
6. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
[TBL] [Abstract][Full Text] [Related]
7. A computational pipeline for quantification of pulmonary infections in small animal models using serial PET-CT imaging.
Bagci U; Foster B; Miller-Jaster K; Luna B; Dey B; Bishai WR; Jonsson CB; Jain S; Mollura DJ
EJNMMI Res; 2013 Jul; 3(1):55. PubMed ID: 23879987
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
10. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
12. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
13. PET attenuation correction using synthetic CT from ultrashort echo-time MR imaging.
Roy S; Wang WT; Carass A; Prince JL; Butman JA; Pham DL
J Nucl Med; 2014 Dec; 55(12):2071-7. PubMed ID: 25413135
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
15. One registration multi-atlas-based pseudo-CT generation for attenuation correction in PET/MRI.
Arabi H; Zaidi H
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2021-35. PubMed ID: 27260522
[TBL] [Abstract][Full Text] [Related]
16. Use of articulated registration for response assessment of individual metastatic bone lesions.
Yip S; Jeraj R
Phys Med Biol; 2014 Mar; 59(6):1501-14. PubMed ID: 24594875
[TBL] [Abstract][Full Text] [Related]
17. Position tracking of moving liver lesion based on real-time registration between 2D ultrasound and 3D preoperative images.
Weon C; Hyun Nam W; Lee D; Lee JY; Ra JB
Med Phys; 2015 Jan; 42(1):335-47. PubMed ID: 25563273
[TBL] [Abstract][Full Text] [Related]
18. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results.
Beiderwellen KJ; Poeppel TD; Hartung-Knemeyer V; Buchbender C; Kuehl H; Bockisch A; Lauenstein TC
Invest Radiol; 2013 May; 48(5):273-9. PubMed ID: 23493121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
